相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease
Lawrence S. Honig et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Using Robust Normative Data to Investigate the Neuropsychology of Cognitive Aging
Karra D. Harrington et al.
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY (2017)
The DIAN-TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model
Randall J. Bateman et al.
ALZHEIMERS & DEMENTIA (2017)
Certified normal: Alzheimer's disease biomarkers and normative estimates of cognitive functioning
Jason Hassenstab et al.
NEUROBIOLOGY OF AGING (2016)
A Novel Approach to Delayed-Start Analyses for Demonstrating Disease-Modifying Effects in Alzheimer's Disease
Hong Liu-Seifert et al.
PLOS ONE (2015)
Estimating long-term multivariate progression from short-term data
Michael C. Donohue et al.
ALZHEIMERS & DEMENTIA (2014)
Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014
L. S. Schneider et al.
JOURNAL OF INTERNAL MEDICINE (2014)
Symptom onset in autosomal dominant Alzheimer disease A systematic review and meta-analysis
Davis C. Ryman et al.
NEUROLOGY (2014)
Clinical and Psychological Characteristics of the Initial Cohort of the Dominantly Inherited Alzheimer Network (DIAN)
Martha Storandt et al.
NEUROPSYCHOLOGY (2014)
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Rachelle S. Doody et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The Preclinical Alzheimer Cognitive Composite Measuring Amyloid-Related Decline
Michael C. Donohue et al.
JAMA NEUROLOGY (2014)
Designing drug trials for Alzheimer's disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task Force
Bruno Vellas et al.
ALZHEIMERS & DEMENTIA (2013)
Combining Multiple Markers to Improve the Longitudinal Rate of Progression: Application to Clinical Trials on the Early Stage of Alzheimer's Disease
Chengjie Xiong et al.
STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2013)
Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
Robert Howard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Designing clinical trials to test disease-modifying agents: application to the treatment trials of Alzheimer's disease
Chengjie Xiong et al.
CLINICAL TRIALS (2011)
Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease
Randall J. Bateman et al.
ALZHEIMERS RESEARCH & THERAPY (2011)
Recent developments in Alzheimer's disease therapeutics
Michael S. Rafii et al.
BMC MEDICINE (2009)
The Delayed-Start Study Design
Ralph B. D'Agostino
NEW ENGLAND JOURNAL OF MEDICINE (2009)
分享论文
